Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MSCI | MSCI Inc. | Chairman and CEO, Director | $988 M | +$6.06 M | +0.62% | Apr 25, 2024 |
RPRX | Royalty Pharma plc | Director | $2.97 M | Jun 28, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|